Stacy Ku
Stock Analyst at TD Cowen
(3.98)
# 1,750
Out of 4,670 analysts
155
Total ratings
48.3%
Success rate
8.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stacy Ku
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AUPH Aurinia Pharmaceuticals | Maintained: Buy | $17 | $16.17 | +5.13% | 17 | Aug 20, 2026 | |
| LENZ LENZ Therapeutics | Rated: Buy | $60 | $4.92 | +1,119.51% | 18 | Aug 12, 2026 | |
| TNXP Tonix Pharmaceuticals Holding | Maintained: Buy | $22 | $12.73 | +72.82% | 4 | Aug 10, 2026 | |
| VRCA Verrica Pharmaceuticals | Rated: Buy | $20 | $4.99 | +300.80% | 15 | Aug 7, 2026 | |
| BCRX BioCryst Pharmaceuticals | Maintained: Buy | $30 | $10.07 | +197.91% | 17 | Aug 5, 2026 | |
| SUPN Supernus Pharmaceuticals | Maintained: Buy | $65 | $48.54 | +33.91% | 21 | Aug 3, 2026 | |
| LON: 0NZT UCB SA | Maintained: Buy | €142.51 → €305.00 | €218.83 | +39.38% | 25 | Aug 3, 2026 | |
| YARW Yarrow Bioscience | Initiated Coverage: Buy | n/a | $40.60 | - | 9 | Jul 27, 2026 | |
| AVTX Avalo Therapeutics | Maintained: Buy | n/a | $20.75 | - | 4 | Jun 11, 2026 | |
| SLGL Sol-Gel Technologies | Initiated Coverage: Buy | n/a | $78.59 | - | 1 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $3.96 | - | 14 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 → $8 | $2.20 | +263.64% | 2 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $165 → $175 | $127.28 | +37.49% | 6 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $6.81 | - | 1 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $16.74 | n/a | 1 | Feb 26, 2025 |
Aurinia Pharmaceuticals
Aug 20, 2026
Maintained: Buy
Price Target: $17
Current: $16.17
Upside: +5.13%
LENZ Therapeutics
Aug 12, 2026
Rated: Buy
Price Target: $60
Current: $4.92
Upside: +1,119.51%
Tonix Pharmaceuticals Holding
Aug 10, 2026
Maintained: Buy
Price Target: $22
Current: $12.73
Upside: +72.82%
Verrica Pharmaceuticals
Aug 7, 2026
Rated: Buy
Price Target: $20
Current: $4.99
Upside: +300.80%
BioCryst Pharmaceuticals
Aug 5, 2026
Maintained: Buy
Price Target: $30
Current: $10.07
Upside: +197.91%
Supernus Pharmaceuticals
Aug 3, 2026
Maintained: Buy
Price Target: $65
Current: $48.54
Upside: +33.91%
UCB SA
Aug 3, 2026
Maintained: Buy
Price Target: €142.51 → €305.00
Current: €218.83
Upside: +39.38%
Yarrow Bioscience
Jul 27, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $40.60
Upside: -
Avalo Therapeutics
Jun 11, 2026
Maintained: Buy
Price Target: n/a
Current: $20.75
Upside: -
Sol-Gel Technologies
May 29, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $78.59
Upside: -
May 20, 2026
Rated: Buy
Price Target: n/a
Current: $3.96
Upside: -
Apr 23, 2026
Rated: Buy
Price Target: $12 → $8
Current: $2.20
Upside: +263.64%
Mar 13, 2026
Maintained: Buy
Price Target: $165 → $175
Current: $127.28
Upside: +37.49%
Oct 30, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $6.81
Upside: -
Feb 26, 2025
Maintained: Buy
Price Target: n/a
Current: $16.74
Upside: n/a